December 4, 2013
Primary and Long-Term Illness Related to E. coli O157 Costs $403.9 Million per Year in Canada
December 2, 2013
Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S.
Latest TSX stock price
All prices delayed at least 15 minutes.Source: TSX Inc.
Latest ASX stock price
All prices delayed at least 20 minutes.Source: ASX Inc.
Inquiries related to stock transfer, lost certificates or address changes should be directed to our Transfer Agent, CIBC Mellon Trust Company.
CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
P.O. Box 700, Station B
Montreal, QC, H3B 3K3
Tel: 1 (800) 387-0825 / (416) 682-3860
Fax: 1 (888) 249-6189
Bioniche financial reports can be downloaded here
Request investor materials by regular mail here
All Bioniche publicly-listed documents can be viewed here
To automatically receive an e-mail alert when Bioniche news releases are posted to this site, enter your e-mail address here.